Marathon Capital Management has filed its 13F form on August 14, 2024 for Q2 2024 where it was disclosed a total value porftolio of $380 Million distributed in 145 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Price T Rowe Group Inc with a value of $99.3M, Astrazeneca PLC with a value of $12.6M, Apple Inc. with a value of $12.4M, Microsoft Corp with a value of $11.4M, and Qualcomm Inc with a value of $11.1M.

Examining the 13F form we can see an decrease of $27.3M in the current position value, from $407M to 380M.

Marathon Capital Management is based out at Hunt Valley, MD

Below you can find more details about Marathon Capital Management portfolio as well as his latest detailed transactions.

Portfolio value $380 Million
Financial Services: $136 Million
Technology: $80.9 Million
Healthcare: $43.1 Million
Energy: $34.1 Million
Industrials: $26 Million
Consumer Cyclical: $15.1 Million
Real Estate: $12.4 Million
Basic Materials: $10.4 Million
Other: $20.8 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 145
  • Current Value $380 Million
  • Prior Value $407 Million
  • Filing
  • Period Q2 2024
  • Filing Date August 14, 2024
  • Form Type 13F-HR
  • Activity in Q2 2024
  • New Purchases 9 stocks
  • Additional Purchases 45 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 63 stocks
Track This Portfolio

Track Marathon Capital Management Portfolio

Follow Marathon Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marathon Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Marathon Capital Management with notifications on news.